The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on 1,2,3-Triacetyl-5-Deoxy-D-Ribose market competitiveness, regional economic performance, and supply chain configurations.
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
The North America 1,2,3-Triacetyl-5-Deoxy-D-Ribose market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of 1,2,3-Triacetyl-5-Deoxy-D-Ribose include AlchemyPharm, Alfa Chemistry, Biosynth Carbosynth, Caming Pharmaceutical, Changzhou Joyous Chemical, Clearsynth, Hefei Home Sunshine Pharmaceutical Technology, Henan Eastar Chem.&Tech, Henan Tianfu Chemical, Ivy Fine Chemicals, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of 1,2,3-Triacetyl-5-Deoxy-D-Ribose market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Purity 98% in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Chemical in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the 1,2,3-Triacetyl-5-Deoxy-D-Ribose value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 1,2,3-Triacetyl-5-Deoxy-D-Ribose Product Scope
1.2 1,2,3-Triacetyl-5-Deoxy-D-Ribose by Type
1.2.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity 97%
1.2.3 Purity 98%
1.2.4 Purity 99%
1.3 1,2,3-Triacetyl-5-Deoxy-D-Ribose by Application
1.3.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Medicine
1.3.3 Chemical
1.3.4 Others
1.4 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Estimates and Forecasts (2020-2031)
1.4.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Size in Value Growth Rate (2020-2031)
1.4.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Market Share by Region (2020-2025)
2.2.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue Market Share by Region (2020-2025)
2.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Size and Prospective (2020-2031)
2.4.2 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Size and Prospective (2020-2031)
2.4.3 China 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Size and Prospective (2020-2031)
2.4.4 Japan 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Historic Market Review by Type (2020-2025)
3.1.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Type (2020-2025)
3.1.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue by Type (2020-2025)
3.1.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Price by Type (2020-2025)
3.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Forecast by Type (2026-2031)
3.2.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue Forecast by Type (2026-2031)
3.2.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Price Forecast by Type (2026-2031)
3.3 Different Types 1,2,3-Triacetyl-5-Deoxy-D-Ribose Representative Players
4 Global Market Size by Application
4.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Historic Market Review by Application (2020-2025)
4.1.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Application (2020-2025)
4.1.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue by Application (2020-2025)
4.1.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Price by Application (2020-2025)
4.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Forecast by Application (2026-2031)
4.2.2 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue Forecast by Application (2026-2031)
4.2.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in 1,2,3-Triacetyl-5-Deoxy-D-Ribose Application
5 Competition Landscape by Players
5.1 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Players (2020-2025)
5.2 Global Top 1,2,3-Triacetyl-5-Deoxy-D-Ribose Players by Revenue (2020-2025)
5.3 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1,2,3-Triacetyl-5-Deoxy-D-Ribose as of 2024)
5.4 Global 1,2,3-Triacetyl-5-Deoxy-D-Ribose Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of 1,2,3-Triacetyl-5-Deoxy-D-Ribose, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of 1,2,3-Triacetyl-5-Deoxy-D-Ribose, Product Type & Application
5.7 Global Key Manufacturers of 1,2,3-Triacetyl-5-Deoxy-D-Ribose, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Company
6.1.1.1 North America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Company (2020-2025)
6.1.1.2 North America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue by Company (2020-2025)
6.1.2 North America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Breakdown by Type (2020-2025)
6.1.3 North America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Breakdown by Application (2020-2025)
6.1.4 North America 1,2,3-Triacetyl-5-Deoxy-D-Ribose Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Company
6.2.1.1 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Company (2020-2025)
6.2.1.2 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue by Company (2020-2025)
6.2.2 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Breakdown by Type (2020-2025)
6.2.3 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Breakdown by Application (2020-2025)
6.2.4 Europe 1,2,3-Triacetyl-5-Deoxy-D-Ribose Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Company
6.3.1.1 China 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Company (2020-2025)
6.3.1.2 China 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue by Company (2020-2025)
6.3.2 China 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Breakdown by Type (2020-2025)
6.3.3 China 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Breakdown by Application (2020-2025)
6.3.4 China 1,2,3-Triacetyl-5-Deoxy-D-Ribose Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Company
6.4.1.1 Japan 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales by Company (2020-2025)
6.4.1.2 Japan 1,2,3-Triacetyl-5-Deoxy-D-Ribose Revenue by Company (2020-2025)
6.4.2 Japan 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Breakdown by Type (2020-2025)
6.4.3 Japan 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales Breakdown by Application (2020-2025)
6.4.4 Japan 1,2,3-Triacetyl-5-Deoxy-D-Ribose Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AlchemyPharm
7.1.1 AlchemyPharm Company Information
7.1.2 AlchemyPharm Business Overview
7.1.3 AlchemyPharm 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AlchemyPharm 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.1.5 AlchemyPharm Recent Development
7.2 Alfa Chemistry
7.2.1 Alfa Chemistry Company Information
7.2.2 Alfa Chemistry Business Overview
7.2.3 Alfa Chemistry 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Alfa Chemistry 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.2.5 Alfa Chemistry Recent Development
7.3 Biosynth Carbosynth
7.3.1 Biosynth Carbosynth Company Information
7.3.2 Biosynth Carbosynth Business Overview
7.3.3 Biosynth Carbosynth 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Biosynth Carbosynth 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.3.5 Biosynth Carbosynth Recent Development
7.4 Caming Pharmaceutical
7.4.1 Caming Pharmaceutical Company Information
7.4.2 Caming Pharmaceutical Business Overview
7.4.3 Caming Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Caming Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.4.5 Caming Pharmaceutical Recent Development
7.5 Changzhou Joyous Chemical
7.5.1 Changzhou Joyous Chemical Company Information
7.5.2 Changzhou Joyous Chemical Business Overview
7.5.3 Changzhou Joyous Chemical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Changzhou Joyous Chemical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.5.5 Changzhou Joyous Chemical Recent Development
7.6 Clearsynth
7.6.1 Clearsynth Company Information
7.6.2 Clearsynth Business Overview
7.6.3 Clearsynth 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Clearsynth 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.6.5 Clearsynth Recent Development
7.7 Hefei Home Sunshine Pharmaceutical Technology
7.7.1 Hefei Home Sunshine Pharmaceutical Technology Company Information
7.7.2 Hefei Home Sunshine Pharmaceutical Technology Business Overview
7.7.3 Hefei Home Sunshine Pharmaceutical Technology 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Hefei Home Sunshine Pharmaceutical Technology 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.7.5 Hefei Home Sunshine Pharmaceutical Technology Recent Development
7.8 Henan Eastar Chem.&Tech
7.8.1 Henan Eastar Chem.&Tech Company Information
7.8.2 Henan Eastar Chem.&Tech Business Overview
7.8.3 Henan Eastar Chem.&Tech 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Henan Eastar Chem.&Tech 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.8.5 Henan Eastar Chem.&Tech Recent Development
7.9 Henan Tianfu Chemical
7.9.1 Henan Tianfu Chemical Company Information
7.9.2 Henan Tianfu Chemical Business Overview
7.9.3 Henan Tianfu Chemical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Henan Tianfu Chemical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.9.5 Henan Tianfu Chemical Recent Development
7.10 Ivy Fine Chemicals
7.10.1 Ivy Fine Chemicals Company Information
7.10.2 Ivy Fine Chemicals Business Overview
7.10.3 Ivy Fine Chemicals 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Ivy Fine Chemicals 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.10.5 Ivy Fine Chemicals Recent Development
7.11 Jiangxi Chibang Pharmaceutical
7.11.1 Jiangxi Chibang Pharmaceutical Company Information
7.11.2 Jiangxi Chibang Pharmaceutical Business Overview
7.11.3 Jiangxi Chibang Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Jiangxi Chibang Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.11.5 Jiangxi Chibang Pharmaceutical Recent Development
7.12 Shandong Boyuan Pharmaceutical
7.12.1 Shandong Boyuan Pharmaceutical Company Information
7.12.2 Shandong Boyuan Pharmaceutical Business Overview
7.12.3 Shandong Boyuan Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Shandong Boyuan Pharmaceutical 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.12.5 Shandong Boyuan Pharmaceutical Recent Development
7.13 Watson
7.13.1 Watson Company Information
7.13.2 Watson Business Overview
7.13.3 Watson 1,2,3-Triacetyl-5-Deoxy-D-Ribose Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Watson 1,2,3-Triacetyl-5-Deoxy-D-Ribose Products Offered
7.13.5 Watson Recent Development
8 1,2,3-Triacetyl-5-Deoxy-D-Ribose Manufacturing Cost Analysis
8.1 1,2,3-Triacetyl-5-Deoxy-D-Ribose Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of 1,2,3-Triacetyl-5-Deoxy-D-Ribose
8.4 1,2,3-Triacetyl-5-Deoxy-D-Ribose Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 1,2,3-Triacetyl-5-Deoxy-D-Ribose Distributors List
9.3 1,2,3-Triacetyl-5-Deoxy-D-Ribose Customers
10 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Dynamics
10.1 1,2,3-Triacetyl-5-Deoxy-D-Ribose Industry Trends
10.2 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Drivers
10.3 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Challenges
10.4 1,2,3-Triacetyl-5-Deoxy-D-Ribose Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published Date: 2024-01-17
Pages: 98
USD 2900.00
(Single User License)
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published Date: 2024-04-12
Pages: 108
USD 4900.00
(Single User License)
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published Date: 2024-01-07
Pages: 127
USD 3950.00
(Single User License)
The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 126
USD 3950.00
(Single User License)
The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-09
Pages: 102
USD 2900.00
(Single User License)
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 155
USD 4900.00
(Single User License)
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 142
USD 2900.00
(Single User License)
The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 141
USD 3950.00
(Single User License)
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published: 2024-01-17
Pages: 98
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published: 2024-04-12
Pages: 108
Triacetyl ribose is an important intermediate for the synthesis of capecitabine, and the capecitabine bulk drug can be prepared in three steps through a route reported in the literature. According to reports in the literature, the synthesis of triacetyl ribose is mainly based on the following two methods: one is using 1-methyl-5-deoxyribose as an intermediate, and triacetyl ribose is obtained through a two-step reaction; the second is using 5-deoxy-D -Ribose is an intermediate and triacetyl ribose is obtained by one-step acetylation. According to the synthetic method reported above, the prepared triacetyl ribose is a mixture of α and β isomers. The β isomer participates in the next reaction to prepare capecitabine. The α isomer is the impurity produced, and the α is different. The ratio of the structure is 3~30%, and the ratio of the α isomer will not be higher. The pure β isomer can be obtained by column chromatography or recrystallization at this isomer ratio.
Published: 2024-01-07
Pages: 127
The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 126
The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-09
Pages: 102
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 155
The global 1,2,3-Triacetyl-5-Deoxy-D-Ribose market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 142
The global market for 1,2,3-Triacetyl-5-Deoxy-D-Ribose was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 141
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
Why This Report?
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report